PMC:7293470 / 109-364 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T3","span":{"begin":2,"end":10},"obj":"SP_7"},{"id":"T4","span":{"begin":12,"end":22},"obj":"SP_7"},{"id":"T5","span":{"begin":151,"end":155},"obj":"GO:0016265"},{"id":"T6","span":{"begin":183,"end":194},"obj":"UBERON:0001004"},{"id":"T7","span":{"begin":231,"end":236},"obj":"UBERON:0000062"},{"id":"T8","span":{"begin":249,"end":254},"obj":"GO:0016265"},{"id":"T81248","span":{"begin":2,"end":10},"obj":"SP_7"},{"id":"T26403","span":{"begin":12,"end":22},"obj":"SP_7"},{"id":"T92715","span":{"begin":151,"end":155},"obj":"GO:0016265"},{"id":"T84467","span":{"begin":183,"end":194},"obj":"UBERON:0001004"},{"id":"T35381","span":{"begin":231,"end":236},"obj":"UBERON:0000062"},{"id":"T53090","span":{"begin":249,"end":254},"obj":"GO:0016265"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":231,"end":236},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma67498"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":231,"end":236},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0000062"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"T3","span":{"begin":12,"end":20},"obj":"Disease"},{"id":"T4","span":{"begin":12,"end":16},"obj":"Disease"},{"id":"T5","span":{"begin":177,"end":212},"obj":"Disease"},{"id":"T6","span":{"begin":183,"end":212},"obj":"Disease"},{"id":"T7","span":{"begin":214,"end":218},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":231,"end":236},"obj":"http://purl.obolibrary.org/obo/UBERON_0003103"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":183,"end":203},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}

{"project":"LitCovid-PubTator","denotations":[{"id":"59","span":{"begin":12,"end":22},"obj":"Species"},{"id":"70","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"71","span":{"begin":151,"end":155},"obj":"Disease"},{"id":"72","span":{"begin":177,"end":212},"obj":"Disease"},{"id":"73","span":{"begin":214,"end":218},"obj":"Disease"},{"id":"74","span":{"begin":231,"end":244},"obj":"Disease"},{"id":"75","span":{"begin":249,"end":254},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"Tax:2697049"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"MESH:C000657245"},{"id":"A71","pred":"tao:has_database_id","subj":"71","obj":"MESH:D003643"},{"id":"A72","pred":"tao:has_database_id","subj":"72","obj":"MESH:D012128"},{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"MESH:D012128"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:D009102"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"h COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death."}